Positive impactResults

Stocks To Buy: Macquarie 'double upgrades' two hospital stocks for up to 37% upside

CNBC-TV18 40 min ago·20 Nov 2026, 3:41 am

Macquarie has raised its target price on two listed hospital companies, saying they could climb as much as 37% from current levels. The broker believes earnings forecasts for the sector have likely hit the low point and that stock valuations have come down, making the shares look cheaper.

For investors, the upgrade suggests that recent pressure on profit margins from hospitals adding new beds is already reflected in share prices, so any further earnings improvement could boost returns. A lower valuation also narrows the gap between the current price and Macquarie’s fair‑value estimate.

Going forward, market participants will watch the next quarterly results, any updates on bed‑capacity expansion, and broader health‑care policy changes that could affect demand. Shifts in interest rates or insurance reimbursements could also influence the sector’s performance.

Excerpt from CNBC-TV18

Published On Nov 20, 2026 | 09:11 IST Last Updated On Nov 20, 2026 | 09:11 IST Macquarie believes consensus earnings estimate for the hospital sector have bottomed out, while valuations have moderated. It also believes the initial impact of profitability pressures from the ongoing bed expansion cycle is already…
Read the original at CNBC-TV18

Key takeaways

  • Category: Results.
  • AI reads the tone as positive (potentially bullish) for the stock.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.

More Sector news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.